Company Filing History:
Years Active: 2019
Title: Da-Wei Yeh: Innovator in Immunogenic Research
Introduction
Da-Wei Yeh is a prominent inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of immunology through his innovative research and patent developments. His work focuses on enhancing immune responses, which is crucial for advancing medical treatments and therapies.
Latest Patents
Da-Wei Yeh holds a patent for a CpG-oligodeoxynucleotide, immunogenic composition including the same, and method of inducing immune response by the same. This patent describes a CpG-oligodeoxynucleotide (CpG-ODN) designed to induce a TLR9 activated immune response, a TLR21 activated immune response, or a combination thereof in a host. The CpG-ODN includes one or more copies of the sequences of GTCGTT, GTT, and TTTT, with specific arrangements that enhance its effectiveness. This innovative approach has the potential to significantly impact immunotherapy and vaccine development.
Career Highlights
Da-Wei Yeh is affiliated with the National Health Research Institutes, where he conducts his research. His work is characterized by a commitment to advancing scientific knowledge and improving health outcomes through innovative solutions. His patent reflects his dedication to addressing complex challenges in immunology.
Collaborations
Da-Wei Yeh collaborates with esteemed colleagues such as Tsung-Hsien Chuang and Chao-Yang Lai. These partnerships enhance the research efforts and contribute to the development of groundbreaking immunogenic compositions.
Conclusion
Da-Wei Yeh's contributions to immunology through his patent and research at the National Health Research Institutes highlight his role as an influential inventor in the field. His innovative work continues to pave the way for advancements in immune response therapies.